SFI
NARI

Susquehanna Fundamental Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Susquehanna Fundamental Investments’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-126,140
Closed -$6.44M – 1258
2024
Q4 		$6.44M Buy
+126,140
New +$6.2M 0.09% 279
2024
Q2 		$6.46M Buy
+134,205
New +$5.95M 0.15% 181
2022
Q1 		$3.15M Sell
34,714
-3,775
-10% -$309K 0.06% 429
2021
Q4 		$3.51M Sell
38,489
-4,443
-10% -$381K 0.09% 276
2021
Q3 		$3.48M Buy
+42,932
New +$3.61M 0.06% 408

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Susquehanna Fundamental Investments's NARI Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 126,140 shares — an estimated $6.44M sold.

Susquehanna Fundamental Investments first reported a position in NARI in Q3 2021 and held it in 5 quarters. The position peaked at $6.46M in Q2 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 126,140 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $6.44M.
  • Susquehanna Fundamental Investments first reported a position in Inari Medical, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Inari Medical, Inc. Common Stock position peaked at $6.46M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.